Back
NovoCure Ltd. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
NVCR
NovoCure Ltd.
Last Price:
$13.28
Seasonality Move:
-11.64%
7 Day Trial
ALL ACCESS PASS
$
7
NovoCure Ltd. Stock Forecast
-
Over the next 52 weeks, NovoCure Ltd. has on average historically risen by 30.1% based on the past 10 years of stock performance.
-
NovoCure Ltd. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is NovoCure Ltd. Stock Undervalued?The current NovoCure Ltd. [NVCR] share price is $13.44. The Score for NVCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will NovoCure Ltd. Stock Go Up Next Year?
-
Over the next 52 weeks, NovoCure Ltd. has on average historically risen by 30.1% based on the past 10 years of stock performance.
NovoCure Ltd. Stock Rating
Sell
44
NovoCure Ltd. (NVCR)
is a Sell
Is NovoCure Ltd. overpriced?
-
NovoCure Ltd. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
NovoCure Ltd. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
novocure.com
52-Week Data
52-Week High:
32.06
52-Week Low:
10.70
Prediction Charts
Market Cap:
1.5B
Price in USD:
13.44
Volume:
1.4M
Beta:
1.01
Technical Analysis
SMA50:
12.57
SMA100:
12.53
SMA200:
14.94
52-Wk Change:
-56.36%
Stock Predictions
-
Is NovoCure Ltd. stock public?Yes, NovoCure Ltd. is a publicly traded company.
-
What is the NovoCure Ltd. stock quote today?The NovoCure Ltd. stock price is 13.44 USD today.
-
How to buy NovoCure Ltd. stock online?You can buy NovoCure Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 10.93 | 11.81 | 11.86 | 10.93 |
| Dec-4 | 11.77 | 11.76 | 11.83 | 11.36 |
| Dec-5 | 11.85 | 12.11 | 12.21 | 11.74 |
| Dec-8 | 12.24 | 12.06 | 12.33 | 11.82 |
| Dec-9 | 12.05 | 12.70 | 12.83 | 12.00 |
| Dec-10 | 12.70 | 13.22 | 13.25 | 12.62 |
| Dec-11 | 13.25 | 13.66 | 13.94 | 13.24 |
| Dec-12 | 13.58 | 13.32 | 13.69 | 13.25 |
| Dec-15 | 13.42 | 12.97 | 13.49 | 12.96 |
| Dec-16 | 12.94 | 12.93 | 13.19 | 12.83 |
| Dec-17 | 12.88 | 12.33 | 13.12 | 12.30 |
| Dec-18 | 12.48 | 12.56 | 12.78 | 12.38 |
| Dec-19 | 12.60 | 12.84 | 12.87 | 12.60 |
| Dec-22 | 12.84 | 13.44 | 13.97 | 12.80 |
NovoCure Ltd. Earnings
NovoCure Ltd. Earnings Report: Per Share NovoCure Ltd. Earnings Q1 Q2 Q3 and Q4 last year and next year.
NovoCure Ltd. Forecast Revenue Growth
NovoCure Ltd. Stock Analysis: Historical quarterly revenues per share for NovoCure Ltd. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.10 per share.
* NovoCure Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.